\-\ Texto\\:\\ \ \(0\)\
\-\ pe\\ unremarkable\\.\\ \ \(0\)\
\-\ cbc\\:\\ 8\\.7\\>14\\.4\\/42\\.3\\<223\ \(0\)\
\-\ bmp\\:\\ 146\\/4\\.5\\/111\\/28\\/24\\/0\\.8\\<91\ \(0\)\
\-\ ua\\:\\ 10\\ rbc\\,\\ \\>100\\ wbc\\,\\ nitrites\\ negative\ \(0\)\
\-\ right\\ radical\\ nephroureterectomy\\/cystoprostatectomy\\ with\\ ileal\\ conduit\ \(0\)\
\-\ bilateral\\ nephrolithiasis\\ with\\ a\\ stone\\ in\\ the\\ proximal\\ right\\ ureter\\ causing\\ obstruction\\ of\\ the\\ right\\ collecting\\ system\\.\\ \\ surrounding\\ enhancing\\ soft\\ tissue\\ density\\ around\\ this\\ stone\\ suggestive\\ of\\ an\\ adjacent\\ mass\\ suspicious\\ for\\ an\\ upper\\ tract\\ lesion\\.\ \(0\)\
\-\ transitional\\ cell\\ carcinoma\\ \\(t2\\ low\\ grade\\ papillary\\ urothelial\\ carcinoma\\)\ \(0\)\
\-\ neoplasm\ \(440\)\
\-\ obstructing\\ stone\ \(10\)\
\-\ infected\\ stone\ \(0\)\
\-\ uti\ \(1153\)\
\-\ 70\\ year\\ old\\ male\\ with\\ history\\ of\\ high\\ grade\\ t1\\ papillary\\ urothelial\\ carcinoma\\ in\\ 2008\\ currently\\ undergoing\\ bcg\\ therapy\\ now\\ with\\ new\\ onset\\ gross\\ hematuria\\ and\\ right\\ sided\\ flank\\ pain\\.\\ denies\\ fevers\\,\\ chills\\,\\ dysuria\\ or\\ other\\ gu\\ symptoms\\.\ \(0\)\
\-\ hematuria\\ work\\-up\\ consists\\ of\\ three\\ \\(3\\)\\ studies\\:\\ 1\\.\\ urine\\ cytology\\,\\ 2\\.\\ ct\\ abdomen\\/pelvis\\ with\\/without\\ contrast\\ \\(ct\\ renal\\ ivp\\,\\ triple\\ phase\\ ct\\,\\ hematuria\\ protocol\\ ct\\)\\,\\ and\\ 3\\.\\ cystoscopy\\.\\ \ \(0\)\
\-\ epidemiology\\ of\\ tcc\\:\ \(0\)\
\-\ \\ \\-\\ accounts\\ for\\ \\~90\\%\\ of\\ all\\ gu\\ cancers\ \(0\)\
\-\ \\ \\-\\ can\\ be\\ multifocal\\ and\\ bilateral\ \(0\)\
\-\ \\ \\-\\ aa\\ \\>\\ caucasian\\ \\=\\ hispanic\\ \\=\\ native\\ americans\\ \\>\\ asians\ \(0\)\
\-\ \\ \\-\\ male\\:female\\ \\ 2\\:1\ \(0\)\
\-\ \\ \\-\\ peak\\ incidence\\ 60\\-70\\ years\\,\\ rarely\\ before\\ 40\ \(0\)\
\-\ \\ \\-\\ bladder\\ \\>\\>\\ upper\\ urinary\\ tract\ \(0\)\
\-\ \\ \\-\\ risk\\ factors\\:\\ smoking\\,\\ exposure\\ to\\ numerous\\ chemical\\ compounds\\ \\(aniline\\ dyes\\,\\ pvc\\)\\,\\ chemotherapy\\,\\ chronic\\ bacterial\\ or\\ schistosomiasis\\ gu\\ infection\\ and\\ stones\\ \\(usually\\ causes\\ scc\\)\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ stone\\:\\ 0\\.27161057521158727\ \(0\)\
\-\ gu\\:\\ 0\\.2563726974178873\ \(0\)\
\-\ hematuria\\:\\ 0\\.19723703118231983\ \(0\)\
\-\ urothelial\\:\\ 0\\.19333523631922803\ \(0\)\
\-\ papillary\\:\\ 0\\.1385513819078652\ \(0\)\
\-\ carcinoma\\:\\ 0\\.1333980959946116\ \(0\)\
\-\ tract\\:\\ 0\\.12455140159282428\ \(0\)\
\-\ 70\\:\\ 0\\.1227531859131557\ \(0\)\
\-\ aniline\\:\\ 0\\.11888371587579641\ \(0\)\
\-\ dyes\\:\\ 0\\.11888371587579641\ \(0\)\
\-\ conduit\\:\\ 0\\.11359973726145131\ \(0\)\
\-\ pvc\\:\\ 0\\.11359973726145131\ \(0\)\
\-\ ct\\:\\ 0\\.11320571750005387\ \(0\)\
\-\ asians\\:\\ 0\\.10985069477131384\ \(0\)\
\-\ bcg\\:\\ 0\\.10694271149607044\ \(0\)\
\-\ compounds\\:\\ 0\\.10694271149607044\ \(0\)\
\-\ grade\\:\\ 0\\.10691194483929252\ \(0\)\
\-\ 223\\:\\ 0\\.10456671615696876\ \(0\)\
\-\ ivp\\:\\ 0\\.10255784072155966\ \(0\)\
\-\ nitrites\\:\\ 0\\.1008176736668313\ \(0\)\
\-\ cystoscopy\\:\\ 0\\.1008176736668313\ \(0\)\
\-\ native\\:\\ 0\\.09928273754262366\ \(0\)\
\-\ americans\\:\\ 0\\.09928273754262366\ \(0\)\
\-\ right\\:\\ 0\\.09858537886476289\ \(0\)\
\-\ tcc\\:\\ 0\\.0979096903915879\ \(0\)\
\-\ schistosomiasis\\:\\ 0\\.094490586910445\ \(0\)\
\-\ epidemiology\\:\\ 0\\.09178465256234875\ \(0\)\
\-\ scc\\:\\ 0\\.09099459887147643\ \(0\)\
\-\ cytology\\:\\ 0\\.08763459705513146\ \(0\)\
\-\ of\\:\\ 0\\.08728649132623681\ \(0\)\
\-\ triple\\:\\ 0\\.08705530636378159\ \(0\)\
\-\ ileal\\:\\ 0\\.08650067394800365\ \(0\)\
\-\ dysuria\\:\\ 0\\.08496573782379602\ \(0\)\
\-\ bmp\\:\\ 0\\.08449179851259454\ \(0\)\
\-\ aa\\:\\ 0\\.08403449212611644\ \(0\)\
\-\ hispanic\\:\\ 0\\.08316537715280471\ \(0\)\
\-\ uti\\:\\ 0\\.08275163145786618\ \(0\)\
\-\ accounts\\:\\ 0\\.08275163145786618\ \(0\)\
\-\ radical\\:\\ 0\\.08235061844078635\ \(0\)\
\-\ 91\\:\\ 0\\.08196157776699386\ \(0\)\
\-\ chemical\\:\\ 0\\.08085963478573498\ \(0\)\
\-\ transitional\\:\\ 0\\.08017358719161734\ \(0\)\
\-\ bilateral\\:\\ 0\\.07990468816345772\ \(0\)\
\-\ cancers\\:\\ 0\\.07984364818262278\ \(0\)\
\-\ infected\\:\\ 0\\.079521856654201\ \(0\)\
\-\ upper\\:\\ 0\\.0794508672465988\ \(0\)\
\-\ obstructing\\:\\ 0\\.0786015759506489\ \(0\)\
\-\ nephrolithiasis\\:\\ 0\\.07802228525929902\ \(0\)\
\-\ peak\\:\\ 0\\.07617631062941227\ \(0\)\
\-\ 2008\\:\\ 0\\.07593271671931345\ \(0\)\
\-\ rbc\\:\\ 0\\.07477869816525584\ \(0\)\
\-\ consists\\:\\ 0\\.07392384128390433\ \(0\)\
\-\ ureter\\:\\ 0\\.07292855666251132\ \(0\)\
\-\ with\\:\\ 0\\.07278220415333751\ \(0\)\
\-\ protocol\\:\\ 0\\.07255079413286858\ \(0\)\
\-\ multifocal\\:\\ 0\\.072183674229176\ \(0\)\
\-\ ua\\:\\ 0\\.07097455244396436\ \(0\)\
\-\ exposure\\:\\ 0\\.07064873810496836\ \(0\)\
\-\ stones\\:\\ 0\\.07017479879376688\ \(0\)\
\-\ collecting\\:\\ 0\\.06971749240728879\ \(0\)\
\-\ bacterial\\:\\ 0\\.06956855484616635\ \(0\)\
\-\ smoking\\:\\ 0\\.06884837743397706\ \(0\)\
\-\ chills\\:\\ 0\\.0676445780481662\ \(0\)\
\-\ undergoing\\:\\ 0\\.06751743660309922\ \(0\)\
\-\ urine\\:\\ 0\\.06654263506690733\ \(0\)\
\-\ suspicious\\:\\ 0\\.06642575630362943\ \(0\)\
\-\ rarely\\:\\ 0\\.06630991647643464\ \(0\)\
\-\ male\\:\\ 0\\.06619687055693071\ \(0\)\
\-\ caucasian\\:\\ 0\\.06608128087957306\ \(0\)\
\-\ gross\\:\\ 0\\.06596844991715133\ \(0\)\
\-\ fevers\\:\\ 0\\.0656357026127571\ \(0\)\
\-\ flank\\:\\ 0\\.06520485693537334\ \(0\)\
\-\ urinary\\:\\ 0\\.06428457623182124\ \(0\)\
\-\ incidence\\:\\ 0\\.06399171233958749\ \(0\)\
\-\ phase\\:\\ 0\\.06361119202879983\ \(0\)\
\-\ factors\\:\\ 0\\.06288194474401268\ \(0\)\
\-\ numerous\\:\\ 0\\.06279359257676986\ \(0\)\
\-\ cbc\\:\\ 0\\.06202427380634455\ \(0\)\
\-\ pe\\:\\ 0\\.06145581444523588\ \(0\)\
\-\ and\\:\\ 0\\.06144470358975967\ \(0\)\
\-\ causing\\:\\ 0\\.06106443684061104\ \(0\)\
\-\ 100\\:\\ 0\\.060987552282785344\ \(0\)\
\-\ suggestive\\:\\ 0\\.060535533741683786\ \(0\)\
\-\ before\\:\\ 0\\.06009866954724312\ \(0\)\
\-\ denies\\:\\ 0\\.05995624305033391\ \(0\)\
\-\ around\\:\\ 0\\.05933391232775929\ \(0\)\
\-\ bladder\\:\\ 0\\.057686921388043697\ \(0\)\
\-\ currently\\:\\ 0\\.05710504372005967\ \(0\)\
\-\ an\\:\\ 0\\.05685371525344256\ \(0\)\
\-\ system\\:\\ 0\\.05671265595629073\ \(0\)\
\-\ causes\\:\\ 0\\.05617183583089078\ \(0\)\
\-\ 40\\:\\ 0\\.05467226443598881\ \(0\)\
\-\ studies\\:\\ 0\\.054531377715149404\ \(0\)\
\-\ risk\\:\\ 0\\.05311635985230698\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.052785373305451494\ \(0\)\
\-\ wbc\\:\\ 0\\.05254253594202796\ \(0\)\
\-\ obstruction\\:\\ 0\\.05207002878586411\ \(0\)\
\-\ or\\:\\ 0\\.05172219873261743\ \(0\)\
\-\ new\\:\\ 0\\.051428677341945624\ \(0\)\
\-\ now\\:\\ 0\\.05102989562266282\ \(0\)\
\-\ neoplasm\\:\\ 0\\.05074735025164738\ \(0\)\
\-\ three\\:\\ 0\\.04990192451141454\ \(0\)\
\-\ unremarkable\\:\\ 0\\.04983660159393171\ \(0\)\
\-\ surrounding\\:\\ 0\\.049578535839201104\ \(0\)\
\-\ density\\:\\ 0\\.04929419230997219\ \(0\)\
\-\ adjacent\\:\\ 0\\.048186338214841556\ \(0\)\
\-\ sided\\:\\ 0\\.04781842098515211\ \(0\)\
\-\ onset\\:\\ 0\\.047734972067660274\ \(0\)\
\-\ usually\\:\\ 0\\.04679894665426539\ \(0\)\
\-\ enhancing\\:\\ 0\\.04656874036836446\ \(0\)\
\-\ proximal\\:\\ 0\\.046442583577227046\ \(0\)\
\-\ t1\\:\\ 0\\.04631763636167303\ \(0\)\
\-\ renal\\:\\ 0\\.04629279003431496\ \(0\)\
\-\ negative\\:\\ 0\\.04602256198775274\ \(0\)\
\-\ years\\:\\ 0\\.045568609582698816\ \(0\)\
\-\ for\\:\\ 0\\.04506296031267011\ \(0\)\
\-\ infection\\:\\ 0\\.04490485779342368\ \(0\)\
\-\ all\\:\\ 0\\.04425203877033104\ \(0\)\
\-\ chronic\\:\\ 0\\.044125309459631085\ \(0\)\
\-\ 10\\:\\ 0\\.043469478263039395\ \(0\)\
\-\ t2\\:\\ 0\\.042769088514614834\ \(0\)\
\-\ therapy\\:\\ 0\\.04271238692515583\ \(0\)\
\-\ low\\:\\ 0\\.04265593097512154\ \(0\)\
\-\ cell\\:\\ 0\\.04252514383687581\ \(0\)\
\-\ high\\:\\ 0\\.0422492289132263\ \(0\)\
\-\ symptoms\\:\\ 0\\.04067390882502624\ \(0\)\
\-\ soft\\:\\ 0\\.03957632564935207\ \(0\)\
\-\ can\\:\\ 0\\.03901057861051091\ \(0\)\
\-\ tissue\\:\\ 0\\.03899639037312501\ \(0\)\
\-\ other\\:\\ 0\\.03860526449607805\ \(0\)\
\-\ in\\:\\ 0\\.03698609668019284\ \(0\)\
\-\ contrast\\:\\ 0\\.036119641635607325\ \(0\)\
\-\ female\\:\\ 0\\.035871836688941124\ \(0\)\
\-\ lesion\\:\\ 0\\.03563961180003847\ \(0\)\
\-\ be\\:\\ 0\\.030156226259548786\ \(0\)\
\-\ the\\:\\ 0\\.02966651634727216\ \(0\)\
\-\ history\\:\\ 0\\.028401675213567998\ \(0\)\
\-\ mass\\:\\ 0\\.028395387206328178\ \(0\)\
\-\ pain\\:\\ 0\\.026601111656269112\ \(0\)\
\-\ this\\:\\ 0\\.025544105520543776\ \(0\)\
\-\ year\\:\\ 0\\.022909714292200532\ \(0\)\
\-\ old\\:\\ 0\\.022001256114919987\ \(0\)\
\-\ to\\:\\ 0\\.01858452131552155\ \(0\)\
